Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference
LEXINGTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced that Dr. Jennifer Buell, President and COO of Agenus, will participate in a fireside chat at the Jefferies 2020 Virtual London Healthcare Conference on Tuesday, November 17, 2020 from 4:25 PM – 4:55 PM GMT / 11:25 AM – 11:55 AM EST.
Registration for the webinar can be done in advance at https://wsw.com/webcast/jeff141/agen/1816875.
A replay will be available after the call on the Events & Presentations page of the Agenus website at https://investor.agenusbio.com/events-and-presentations.
Key Tools of the IoT Security Trade
All Conference Party